FDA Set to Clear Third Covid Shot for Immunocompromised

Dr. Chris Beyrer, Professor in Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health, discusses the FDA's plan to clear a third dose of Covid vaccines for people with weak immune systems. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Technology Reporter Drake Bennett explain that as incentives fail to entice people to get vaccinated, businesses are now looking to employee mandates. Bloomberg Opinion Columnist Tara Lachapelle breaks down why even Disney profits are not safe from the delta variant. And we Drive to the Close with Mace McCain, Chief Investment Officer at Frost Investment Advisors.

Host: Carol Massar. Producer: Paul Brennan.

See omnystudio.com/listener for privacy information.